Liposomal drug delivery to the lungs: a post covid-19 scenario
Description
High local delivery of anti-infectives to the lungs is required for activity against infections of the lungs. The present pandemic has highlighted the potential of pulmonary delivery of anti-infective agents as a viable option for infections like
